MED17

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MED17 mutation is significantly associated with the RNA expression of many other genes, with 1,407 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MED17-associated genes across cancer lineages are MIR548C, C1GALT1P3, and MIR3690. Each is linked with MED17 in more than 1 cancer types. Because this analysis shows association rather than direction, both MED17-to-partner and partner-to-MED17 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, MIR548C grouped by MED17-low versus MED17-high in HNSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MED17→partner) and Y-score (partner→MED17) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCMIR548C →+0.377+5.124.001.00832
SKCMC1GALT1P3 →+0.396+3.424<.001.00932
SKCMMIR3690 →+0.574+3.749<.001.00132
LUSCRNU6-1177P →+0.383+3.277.003.00432
LUSCTUBB8P3 →+0.079+3.861<.001.00132
UCECRNA5SP412 →+0.360+2.104.003<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,407 associations by consensus.

MIR548C by MED17 expression — HNSC

Box plot of MIR548C in MED17-low vs MED17-high samples in HNSC.

Explore this box plot interactively →

Exploration